2004, Number 5
<< Back Next >>
Med Cutan Iber Lat Am 2004; 32 (5)
Localized Wegener’s Granulomatosis
Fernandes NC, Fernandes MLF, Cuzzi T
Language: Spanish
References: 13
Page: 218-222
PDF size: 429.07 Kb.
Text Extraction
Wegener’s granulomatosis is characterized by necrotizing granulomas with vasculitis in the upper and lower respiratory tracts and kidneys. It is described a case limited to skin and palate in a 22 year-old female, with a course of two years. The diagnosis was essentially clinical, supported by histopathologic findings of granulomatous inflamation without bacteria and fungi besides therapeutic response to pulses with dexamethasone and cyclophosphamide.
REFERENCES
Fernandes NC, Cardoso ICL, Serpa SS, Rettore FC, et al. Granulomatose de Wegener localizada: relato de caso. An bras Dermatol 1996; 71: 41-4.
Fernandes NC, Paes C, Castilho M, Maceira J. Granulomatose de Wegener localizada com manifestação ocular: relato de caso. An bras Dermatol 1998; 73: 107-10.
Lloyd G, Lund VJ, Beale T, Howard D. Rhinologic changes in Wegener’s granulomatosis. J Laryngol Otol 2002; 116: 565-9.
Galli J, Conna L, Larocca LM. Unusual case of pharyngeal-laryngeal Wegener’s granulomatosis. Acta Otorhinolaryngol 2001; 21: 187-91.
Paulsen JI, Rudert H. Manifestations of primary vasculitis in the ENT region. Z Rheumatol 2001; 60: 219-25.
Kuchel J, Lee S. Cutaneous Wegener’s granulomatosis: a variant or atypical localized form? Australas J Dermatol 2003; 44: 129-35.
Fechner FP, Faquin WC, Pilch BZ. Wegener’s granulomatosis of the orbit: a clinicopathological study of 15 patients. Laryng 2002; 112: 1945-50.
Flach AJ. Ocular manifestations of Wegener’s granulomatosis. JAMA 1995; 274: 1199-200.
Sneller MC. Wegener’s granulomatosis. JAMA 1995; 6: 2938-42.
Dilhuydy MS, Mercié P, Viallard JF, Dumont T, et al. Natural killer cell nasal lymphoma mimicking localized Wegener’s disease. Rev Med Interne 2001; 22: 571-75.
Hoffman GS, Leavitt RY, Fleisher TA, Minor JR, Fauci AS. Treatment of Wegener’s granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med 1990; 89: 403-10.
Stone JH, Uhlfelder ML, Hellmann, Crook S, et al. Etanercept combined with conventional treatment in Wegener’s granulomatosis: a six-month open-label trial to evaluate safety. Arthritis Rheum 2001; 44 (5): 1149-54.
Takagi D, Nakamaru Y, Maguchi S, Furuta Y, Fukuda S. Otologic manifestations of Wegener’s granulomatosis. Laryng 2002; 112: 1684-90.